Identification of biomarkers and their functions in dasatinib-resistant pancreatic cancer using bioinformatics analysis

Dasatinib is a tyrosine kinase inhibitor, which inhibits tumor proliferation by blocking SRC pathways and is considered as a potential treatment of various epithelial neoplasms, including pancreatic cancer. However, dasatinib efficacy is largely limited due to drug resistance. In the present study,...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jingsun, Han, Rongbo, Su, Xinyu, Chen, Yuetong, Shi, Junfeng, Cui, Xiaowen, Zhang, Honghong, Gong, Yang, Chu, Xia, Chen, Jinfei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2019
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540339/
https://www.ncbi.nlm.nih.gov/pubmed/31289489
http://dx.doi.org/10.3892/ol.2019.10281

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6540339/
https://www.ncbi.nlm.nih.gov/pubmed/31289489
http://dx.doi.org/10.3892/ol.2019.10281

Ejemplares similares